coumarin has been researched along with ethyl biscoumacetate in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 112 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
TOOHEY, M | 1 |
BECK, DF; SCARRONE, LA; WRIGHT, IS | 1 |
PAMPURIK, E | 1 |
GRUBER, CM; LEE, KS; RIEDERS, F | 1 |
VAN BUSKIRK, WC | 1 |
VUILLEUMIER, P | 2 |
BRUCKNEROVA, O | 1 |
KOLLAR, K | 1 |
BRODIE, BB; BURNS, JJ; SIMSON, G; WEINER, M; YALE, EK | 1 |
PROCHAZKA, Z | 1 |
HUNTER, RB; TUDHOPE, GR | 1 |
HALSE, T | 1 |
DELLA SANTA, R | 1 |
POLLITZER, RS | 1 |
BRODIE, BB; BURNS, JJ; SIMSON, G; WEINER, M | 1 |
KONIG, FE | 1 |
BRODIE, BB; BURNS, JJ; SIMSON, G; STEELE, JM; WEINER, M | 1 |
BOYER, FR; FUNK, EH; KELLER, EA; VANDER VEER, JB | 1 |
SCHIAVINA, GP | 1 |
CHRIST, M; KELLER, M | 1 |
STEPHAN, E | 1 |
WICKE, G | 1 |
AVELLANEDA, M; CASTRO, CM; STRITZLER, G | 2 |
SCHELLENBERG, W | 1 |
FERRER, J; GARCIA TURIELLA, R; GASPARY, FV; TUERO, PR | 1 |
AFANAS'EVA, LM | 1 |
LASCH, HG; LINKE, A | 1 |
DIENSTBIER, Z; LIBANSKY, J; POLAK, B | 4 |
EGOROVA, LI; LIUTROVNIK, BV | 1 |
CHRIST, MA | 1 |
HILDEN, T; MUNCK, O | 1 |
FRIEDMAN, IA; OLWIN, JH | 1 |
REIST, A | 1 |
GIULINI, R | 1 |
SCHIAVINA, P | 1 |
STAMM, H | 1 |
BOURGAIN, R; HERZIG, L; SYMONS, C; TODD, M; WRIGHT, IS | 1 |
BORTOLOTTI, GC; FACCHINI, G | 1 |
CHATTERJEA, JB; SALOMON, L | 1 |
CHALMERS, JN; DIXON, MF; POLACK, W | 1 |
AEPPLI, H; PULVER, R | 1 |
HULE, V | 1 |
SERT, AS | 1 |
BELLER, FK | 1 |
KLABUSAY, L; KROUTIL, M; LENFELD, J | 1 |
CASTRO, C; STRITZLER, G | 1 |
IVERSEN, T | 1 |
DOUGLAS, AS | 1 |
ALEKSANDROW, D; ASKANAS, Z; OSINSKI, T; WIECLAWEK, B; WYSZNACKA, W | 1 |
CASTRO, CM; STRITZLER, G | 1 |
FUCIK, K; HAIS, IM; KAKAC, B; KNOBLOCH, E; PROCHAZKA, Z | 2 |
BROSSEAU, C; MAROIS, A | 1 |
HUNKA, R; SZINNYAI, M; TREIT, S; VARJASI, F | 2 |
GATTONI, L; SAITA, G | 1 |
LINDAHL, O | 1 |
CATALANO, V; NAVAZIO, F | 1 |
MCELFRESH, AE; OZGE, A | 1 |
MOLLISON, AW; NEILSON, JM | 1 |
BEVILACQUA, M; COLLI, A | 1 |
ESTES, JE; FAIRBAIRN, JF | 1 |
KRANEPUHL, F | 1 |
DERECHIN, M | 1 |
FURIAN, R | 1 |
GUIDO, JJ; PARANO, JR; PERRETTA, A; RASCOVAN, S; SANSUSTE, A | 1 |
HELLEMANS, J; VERMYLEN, C; VERSTRAETE, M; VORLAT, M | 1 |
BARRETT, JL; MADER, IJ; NALBANDIAN, RM; PEARCE, JF; RUPP, EC | 1 |
HOCKERTS, T; MULKE, G | 1 |
BONIVER, G; DRAGO, E; GAVINI, R | 1 |
DUSINSKY, G; GRUNTOVA, Z | 1 |
STAHL, H | 1 |
HORWITZ, M; SOUGIN-MIBASHAN, R | 1 |
GRIFFITHS, FE | 1 |
HRABANE, J; KARASEK, F; MANGAKIS, N; NEUMANN, J; POKORNY, J; REINIS, Z; TRAVNICEK, T; VANECEK, R | 1 |
CERMAK, L; GREGOR, O; HYNIE, J; POKORNY, J | 1 |
REINIS, Z | 1 |
HERLES, F; JAROSOVA, V | 1 |
BURESOVA, A; GROSSMANN, V; HAIS, IM; HOLUBOVA, E; KREJCI, F; LEDVINOVA, Z; MICHALEC, C; SLAVIK, K; TRCKA, V; VAICENBACHEROVA, V; WENKE, M | 1 |
PROCHAZKA, Z; TRCKA, V | 1 |
AVELLANEDA, M | 1 |
GLOOR, F; SIGG, B | 1 |
MAGNANI, B | 1 |
ILLINGWORTH, DG | 1 |
ZWIAUER, A | 1 |
GROSSMANN, V; KASALICKY, B | 1 |
FRANCOVA-KLIMOVA, V; HOLUBOVA, E; TRCKA, V | 1 |
HOUGIE, C | 1 |
GRIPE, RP | 1 |
GILCHRIST, AR; TULLOCH, JA | 1 |
BRONSTEIN, MR; WITKIND, E | 1 |
HOLUBOVA, E; HORAKOVA, Z; MACOVA, S; TRCKA, V | 1 |
BARKER, NW; HANSON, HH; MANN, FD | 1 |
GRUBER, CM; RIEDERS, F | 1 |
GOLDAMMER, HG | 1 |
GRUBER, CM; LASZICZENKO, T; LEE, KS | 1 |
BROWN, A; DOUGLAS, AS | 1 |
BURKE, GE; SCARONE, LA; WRIGHT, IS | 1 |
CHRIST, MA; MERZ, WR | 1 |
COSTANTINI, A; TINTORI, M | 2 |
LINKE, A | 1 |
ALCALA, F; LANG, H; OBE, G | 1 |
PUNDEL, JP | 1 |
BRUERA, EF; DE ROSA, J; GARCIA TUIRELLA, R | 1 |
112 other study(ies) available for coumarin and ethyl biscoumacetate
Article | Year |
---|---|
Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
Topics: Anticoagulants; Antifibrinolytic Agents; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hemostatics; Heparin Antagonists; Humans; Naphthoquinones; Phenindione; Prothrombin; Vitamin K | 1952 |
A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
Topics: American Heart Association; Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate; Thromboembolism; United States | 1952 |
[Hazards in pelentan therapy].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
Further pharmacologic aspects of tromexan (pelantan or ethyl biscumacetate).
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan.
Topics: Antifibrinolytic Agents; Coumarins; Ethyl Biscoumacetate; Hemostatics; Humans; Hypoprothrombinemias; Injections, Intravenous; Retinoids; Vitamin K; Vitamin K 1 | 1953 |
[Tromexan therapy of thrombophlebitis].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis | 1952 |
[Experience with the treatment of thrombophlebitis with simultaneous application of pelentan and vitamin E].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis; Vitamin E | 1952 |
[Experiences with pelentan therapy of acute rheumatism in adults].
Topics: Adult; Coumarins; Ethyl Biscoumacetate; Humans; Rheumatic Diseases; Rheumatic Heart Disease | 1952 |
The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
Topics: Coumarins; Ethyl Biscoumacetate; Regression Analysis | 1952 |
[Studies on anticoagulants; pelentan metabolites in human and rabbit urine].
Topics: Animals; Anticoagulants; Body Fluids; Coumarins; Ethyl Biscoumacetate; Rabbits | 1952 |
Mode of action of tromexan.
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate | 1953 |
[Real or apparent value of tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
[The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Ethyl Biscoumacetate; Myocardial Infarction | 1952 |
Ethyl biscoumacetate (tromexan) in coronary artery disease.
Topics: Coronary Artery Disease; Coronary Disease; Coumarins; Diuretics; Ethyl Biscoumacetate; Humans | 1953 |
The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
Topics: Animals; Biotransformation; Coumarins; Dogs; Ethyl Biscoumacetate; Rabbits | 1953 |
[Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Gynecology; Heparin; Obstetrics; Thromboembolism; Thrombosis | 1953 |
The control of prothrombin activity with tromexan therapy.
Topics: Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Hematologic Tests; Prothrombin; Prothrombin Time; Psychotherapy | 1953 |
Clinical evaluation of ethyl biscoumacetate (tromexan).
Topics: Coumarins; Ethyl Biscoumacetate | 1953 |
[Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
Topics: 4-Hydroxycoumarins; Coumarins; Ethyl Biscoumacetate; Female; Gynecology; Humans; Obstetrics; Thrombophlebitis; Venous Thrombosis | 1953 |
[A new possibility of tromexan detection in the milk].
Topics: Animals; Breast; Coumarins; Dairy Products; Ethyl Biscoumacetate; Milk | 1953 |
[The use of tromexan in thrombophlebitis; two years of experience in the Clinique de la Source, in Lausanne].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis | 1953 |
[Rapid cicatrization of an atonic wound after treatment with tromexan].
Topics: Cicatrix; Coumarins; Ethyl Biscoumacetate; Humans; Wounds and Injuries | 1953 |
[Clinical experiences with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1953 |
[A new anticoagulant, tromexan; its action in health and disease and the interference of other medicinals].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Health | 1953 |
[Puerperal thrombosis, treatment with tromexan, control of prothrombin activity according to Pedrazzini, Salvidio and F. Koller].
Topics: Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Female; Humans; Postpartum Period; Prothrombin; Prothrombin Time; Thrombosis; Vascular Diseases | 1953 |
[Anticoagulant therapy with tromexan].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate | 1953 |
[Pelentan therapy of thrombophlebitis].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis | 1953 |
[Blood coagulation and liver function. II. Tromexan as liver function test].
Topics: Blood Coagulation; Coumarins; Digestion; Ethyl Biscoumacetate; Liver; Liver Function Tests | 1953 |
[Relation of pelentan to vitamin K].
Topics: Coumarins; Ethyl Biscoumacetate; Vitamin K | 1953 |
[Observations on the therapeutic use of pelentan in cardiovascular diseases].
Topics: Cardiovascular Diseases; Coumarins; Ethyl Biscoumacetate | 1953 |
[The secretion of drugs, especially 3,3' carboxymethylene bis (4-hydroxycoumarin) ethyl ester, tromexan, in human milk].
Topics: 4-Hydroxycoumarins; Coumarins; Esters; Ethyl Biscoumacetate; Hemostatics; Humans; Infant; Infant Nutritional Physiological Phenomena; Milk, Human; Prothrombin | 1954 |
Vitamin K as antagonist to anticoagulants; the effect of synthetic vitamin K (menadione) and vitamin K1 in hypoprothrombinemia induced by dicoumarol, tromexan and phenylindanedione.
Topics: Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hemostatics; Humans; Hypoprothrombinemias; Phenindione; Prothrombin; Vitamin K; Vitamin K 1; Vitamin K 3 | 1953 |
[Tromexan; its effect on normal subjects and in certain pathological states].
Topics: Coumarins; Ethyl Biscoumacetate | 1954 |
The control of tromexan therapy.
Topics: Coumarins; Ethyl Biscoumacetate | 1954 |
[Tromexan in selective prevention of thrombo-embolic diseases in puerperium].
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Female; Humans; Postpartum Period; Thromboembolism | 1954 |
[The tromexan liver function test].
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Liver Function Tests | 1954 |
[Clinical aspects of three cases of phlebothrombosis in pregnancy treated with anticoagulating substances (heparin, tromexan)].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Thrombophlebitis; Venous Thrombosis | 1954 |
[Experience with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Thromboembolism | 1954 |
A comparative study of marcumar, tromexan and dicumarol, determination of plasma levels and prothrombin times after intravenous injection.
Topics: Blood; Coumarins; Dicumarol; Ethyl Biscoumacetate; Injections, Intravenous; Phenprocoumon; Plasma; Prothrombin Time | 1954 |
[The test of tromexan hypoprothrombinemia in the study of hepatic function].
Topics: Coumarins; Digestion; Ethyl Biscoumacetate; Hemostatics; Hypoprothrombinemias; Liver Function Tests; Prothrombin | 1954 |
Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate.
Topics: Adrenocorticotropic Hormone; Anticoagulants; Cortisone; Coumarins; Ethyl Biscoumacetate; Hostility | 1954 |
Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.
Topics: Antifibrinolytic Agents; Coumarins; Ethyl Biscoumacetate; Heparin Antagonists; Naphthoquinones; Phenindione; Thromboembolism; Vitamin K; Vitamin K 1 | 1954 |
[Tromexan excretion in human milk].
Topics: Biological Transport; Body Fluids; Coumarins; Ethyl Biscoumacetate; Milk, Human | 1954 |
[Modifications of factor VII and prothrombin in plasma and serum following administration of pelentan].
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate; Factor VII; Hemostatics; Humans; Pharmaceutical Preparations; Plasma; Prothrombin; Prothrombin Time | 1954 |
[Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
Topics: Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Factor V; Prothrombin Time; Salicylates; Sodium Salicylate | 1954 |
[Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Pentosan Sulfuric Polyester; Thrombosis | 1954 |
[Effect of Melilotus officinalis tea and its comparison with pelentan].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Melilotus; Plants; Tea | 1954 |
[Prolonged treatment with tromexan in arteriosclerosis obliterans and in nonacute aorto-iliac obstructions].
Topics: Aorta; Aortic Diseases; Arteriosclerosis; Arteriosclerosis Obliterans; Coumarins; Disease; Ethyl Biscoumacetate; Humans | 1955 |
[Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Factor VII; Humans; Phenprocoumon; Prothrombin; Thrombosis | 1955 |
The coagulation defect caused by tromexan therapy.
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate | 1955 |
[Toxicity of pelentan in chronic circulatory insufficiency].
Topics: Coumarins; Ethyl Biscoumacetate; Heart Failure; Humans | 1954 |
Long-term treatment of some arteriopathies with tromexan.
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Long-Term Care; Peripheral Vascular Diseases; Vascular Diseases | 1955 |
[Chemical characteristics of the main product of anticoagulant pelentan in human urine].
Topics: Anticoagulants; Body Fluids; Coumarins; Ethyl Biscoumacetate; Humans; Urine | 1955 |
[Anticoagulant therapy; tromexan and G-23350].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate | 1955 |
[Pelentan therapy in puerperal thrombosis].
Topics: Coumarins; Ethyl Biscoumacetate; Female; Humans; Infant, Newborn; Postpartum Period; Puerperal Disorders; Thrombosis; Vascular Diseases | 1955 |
[Tromexan load-test in lead poisoning].
Topics: Coumarins; Ethyl Biscoumacetate; Lead Poisoning | 1955 |
[Thrombotic diseases, especially treatment with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Thromboembolism; Thrombosis | 1956 |
Chemical characterization of the main metabolic product of the anticoagulant drug, pelentan, in human urine.
Topics: Anticoagulants; Biochemical Phenomena; Body Fluids; Coumarins; Ethyl Biscoumacetate; Humans; Urine | 1955 |
[A case of ingestion of ethyl ester of bis-4-oxycoumarinyl acetic acid (tromexan) in suicide attempt].
Topics: Acetates; Acetic Acid; Coumarins; Esters; Ethyl Biscoumacetate; Poisoning; Suicide; Suicide, Attempted | 1956 |
The effect of coumarin drugs upon plasma thromboplastin component.
Topics: Blood Coagulation; Coumarins; Dicumarol; Ethyl Biscoumacetate; Factor IX | 1957 |
Clinical evaluation of three anticoagulants in thrombo-embolic disease.
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Phenindione; Prothrombin Time; Thromboembolism | 1957 |
[Experimental histopathological studies of the toxicity of indirect anticoagulants].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans; Phenindione | 1957 |
Clinical experience with 3-(1-phenylpropyl)-4-hydroxycoumarin.
Topics: 4-Hydroxycoumarins; Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Thromboembolism | 1957 |
[Postoperative thromboses & embolisms; causes, prophylaxis & treatment].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Surgical Procedures, Operative; Thromboembolism | 1957 |
An effect of drugs derived from 4-hydroxycoumarins not depending on hypoprothrombinaemia.
Topics: 4-Hydroxycoumarins; Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Hypoprothrombinemias; Psoriasis | 1957 |
[Effect of drugs with coumarin action on fragility of micro-vessels; protective action of ascorbic acid, a methyl-esculetol derivative and mesinositol].
Topics: Ascorbic Acid; Capillaries; Cardiovascular System; Coumarins; Ethyl Biscoumacetate; Inositol; Vitamins | 1957 |
[Use of dicumarol derivatives in diseases of the blood vessels].
Topics: Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Thromboembolism | 1957 |
ON THE CONCEPT OF SLOWLY AND RAPIDLY ACTING COUMARIN DRUGS.
Topics: Blood Coagulation; Coumarins; Dogs; Ethyl Biscoumacetate; Pharmacology; Research | 1963 |
PETECHIAE, ECCHYMOSES, AND NECROSIS OF SKIN INDUCED BY COUMARIN CONGENERS: RARE, OCCASIONALLY LETHAL COMPLICATION OF ANTICOAGULANT THERAPY.
Topics: Acenocoumarol; Anticoagulants; Coumarins; Dicumarol; Drug Therapy; Ecchymosis; Ethyl Biscoumacetate; Gangrene; Necrosis; Phenindione; Pulmonary Embolism; Purpura; Skin Diseases; Thrombophlebitis; Toxicology; Warfarin | 1965 |
[Animal experiments on the effect of the anticoagulant tromexan on coronary blood flow and oxygen consumption of the heart].
Topics: Animal Experimentation; Animals; Anticoagulants; Coronary Vessels; Coumarins; Ethyl Biscoumacetate; Heart; Humans; Metabolism; Myocardium; Oxygen Consumption | 1955 |
[Hepatic function in infants in relation to alimentation: tromexan tolerance test and electrophoresis of blood proteins].
Topics: Blood Proteins; Coumarins; Digestion; Electrophoresis; Ethyl Biscoumacetate; Liver Function Tests | 1954 |
[Pelentan treatment of thromboembolism following a gynecological operation].
Topics: Coumarins; Ethyl Biscoumacetate; Female; Genital Diseases, Female; Gynecologic Surgical Procedures; Humans; Thromboembolism | 1954 |
[Photocolorimetric determination of di-(4-hydroxycumarinyl-3) acetic acid (pelentan)].
Topics: Acetates; Acetic Acid; Colorimetry; Coumarins; Ethyl Biscoumacetate | 1954 |
[Hemorrhage due to tromexan in eruption caused by penicillin].
Topics: Coumarins; Drug Eruptions; Ethyl Biscoumacetate; Exanthema; Hemorrhage; Humans; Penicillins; Tooth Eruption | 1955 |
The uricosuric action of ethyl biscoumacetate.
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Uric Acid; Urine | 1955 |
Ethyl biscoumacetate as an inhibitor of sickling.
Topics: Anemia; Anemia, Sickle Cell; Coumarins; Ethyl Biscoumacetate; Humans | 1955 |
[Development and prevention with pelentan of alimentary atheromatosis in rabbits].
Topics: Animals; Arteriosclerosis; Atherosclerosis; Biomedical Research; Coumarins; Ethyl Biscoumacetate; Rabbits | 1952 |
[Anticoagulant therapy of priapism with pelentan in chronic myeloid leukemia].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Priapism | 1952 |
[Hazards in pelentan therapy].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
[Pelentan therapy of arterial thrombosis and embolism].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Thrombosis | 1952 |
[Hazards and indications for pelentan therapy of myocardial infarction].
Topics: Cardiovascular Diseases; Coumarins; Ethyl Biscoumacetate; Myocardial Infarction | 1952 |
[Comparative results of prolonged administration in rats of pelentan and of 1,1-bis(4-hydroxy-3-coumarinyl)-propanone].
Topics: Animals; Coumarins; Ethyl Biscoumacetate; Propane; Rats | 1952 |
[Studies on anticoagulants. XXVIII. A new highly active anticoagulant analogue pelentan].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans; Inorganic Chemicals; Organic Chemicals | 1955 |
[Interference of barbiturates in the action of tromexan].
Topics: Barbiturates; Coumarins; Ethyl Biscoumacetate | 1955 |
[Prophylaxis of thrombosis with tromexan in closed fractures of the leg].
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate; Fractures, Bone; Fractures, Closed; Humans; Leg; Thrombosis | 1950 |
[Advantages of a new coumarin derivative].
Topics: Coumarins; Ethyl Biscoumacetate | 1951 |
Tromexan and dicoumarol.
Topics: Coumarins; Dicumarol; Ethyl Biscoumacetate | 1951 |
[Method of prothrombin time test in the control of pelentan therapy].
Topics: Coumarins; Ethyl Biscoumacetate; Hemostatics; Humans; Prothrombin; Prothrombin Time | 1951 |
[Possibility of tromexan therapy of anterior chamber inflammations of the eye].
Topics: Anterior Chamber; Coumarins; Ethyl Biscoumacetate; Eye Diseases; Humans; Inflammation | 1951 |
[Effect of pelentan on blood cholinesterase in certain animals and men].
Topics: Animals; Cholinesterases; Coumarins; Ethyl Biscoumacetate; Humans; Male | 1951 |
[Effect of pelentan on blood coagulation in rabbits].
Topics: Animals; Blood Coagulation; Coumarins; Ethyl Biscoumacetate; Lagomorpha; Rabbits | 1951 |
[Reaction determining blood prothrombin activity and control of pelentan therapy from the practical viewpoint].
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Prothrombin | 1951 |
Tromexan therapy; dosage and indications.
Topics: Coumarins; Ethyl Biscoumacetate; Humans | 1951 |
Severe hemorrhage due to tromexan; report of three cases.
Topics: Coumarins; Ethyl Biscoumacetate; Hemorrhage; Humans | 1951 |
Tromexan in the treatment of coronary thrombosis.
Topics: Cardiotonic Agents; Coronary Disease; Coronary Thrombosis; Coumarins; Ethyl Biscoumacetate; Humans | 1951 |
Clinical experience with the anticoagulant, tromexan.
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate | 1951 |
[Modification of prothrombin time during storage of normal rabbit plasma and with added pelentan].
Topics: Animals; Coumarins; Ethyl Biscoumacetate; Plasma; Prothrombin; Prothrombin Time; Rabbits | 1951 |
Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate | 1952 |
Spectrophotometric determination of Tromexan in plasma and serum.
Topics: Coumarins; Ethyl Biscoumacetate; Plasma; Spectrophotometry | 1951 |
[Tromexan prophylaxis and therapy of thrombosis].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombosis | 1951 |
A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin.
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans | 1951 |
Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.
Topics: Antifibrinolytic Agents; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hypoprothrombinemias; Naphthoquinones; Prothrombin; Vitamin K | 1952 |
[Experimental and clinical results with Tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Hemostatics; Prothrombin | 1951 |
NEW and nonofficial remedies; ethyl biscoumacetate.
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
[Prevention of thrombosis with tromexan in puerperium].
Topics: Coumarins; Ethyl Biscoumacetate; Female; Humans; Postpartum Period; Thrombosis | 1952 |
[Mechanism of action of tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1951 |
[Modifications of heparin activity in the blood after tromexan administration].
Topics: Coumarins; Ethyl Biscoumacetate; Heparin; Humans | 1951 |
[Comparative studies on the effect of dicumarol and tromexan on prothrombin level, capillary resistance and capillary permeability].
Topics: Capillaries; Capillary Permeability; Capillary Resistance; Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Prothrombin | 1952 |
[Tromexan in the treatment of thrombosis and embolism in urology].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Thrombosis; Urology | 1952 |
[Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
Topics: Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hemostatics; Prothrombin | 1952 |
[Resorption of arterial embolus by tromexan].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Physiological Phenomena | 1952 |
[Experience with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |